Skip to main content

Table 1 Patient characteristics

From: Influence of the atrio-ventricular delay optimization on the intra left ventricular delay in cardiac resynchronization therapy

Age(mean ± SD)

63.2 ± 11.7

Gender (m/f) (n/%)

7(63.6)/4(36.4%)

Coronary artery disease (n/%)

4 (36.4%)

Dilated Cardiomyopathy (n/%)

7 (63.6%)

Left-ventricular ejection fraction (mean ± SD)

27.3% ± 11.9

Interval in months between stress testing and ICD implantation (months) (mean ± SD)

11.9 ± 12.9

location of the CS – electrode

lateral

6 (54%)

posterolateral

4 (36.4%)

anterolateral

1 (9%)

diabetes mellitus (n/%)

6 (54%)

medication

ACE inhibitors (n/%)

9 (82%)

ARB (n/%)

2 (18%)

Beta-blockers (n/%)

10 (91%)

Digitalis (n/%)

8 (73%)

Diuretics (n/%)

11 (100%)

spironolactone (n/%)

8 (73%)

  1. ARB = Angiotensin-receptor blockers;
  2. CS = coronary sinus